AMHR2 agonist program (Celmatix)

N/A

Report date: 2025/03/14 16:37:02
NME

Base Information

Drug NameAMHR2 agonist program (Celmatix)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnti-Mullerian hormone receptor II agonists
TargetsAnti-Mullerian hormone receptor II
Therapy Area/IndicationsMenopausal symptomsPrimary Ovarian Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelmatix Inc
China Registration ClassN/A

Develop Information

Active CompaniesCelmatix Inc
Inactive CompaniesN/A
Active IndicationsMenopausal symptomsPrimary Ovarian Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A